Welcome to LookChem.com Sign In|Join Free

CAS

  • or

31602-11-6

Post Buying Request

31602-11-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

31602-11-6 Usage

General Description

4-CHLORO-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER is a chemical compound with the molecular formula C15H10ClF3NO2. It is an ethyl ester derivative of 4-chloro-8-(trifluoromethyl)quinoline-3-carboxylic acid. 4-CHLORO-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER belongs to the class of quinoline carboxylic acid esters, which are used in the synthesis of pharmaceuticals and agrochemicals. It is a yellowish crystalline solid that is sparingly soluble in water but soluble in common organic solvents. 4-CHLORO-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER has potential applications in medicinal chemistry and drug discovery due to its diverse biological activities and structural features.

Check Digit Verification of cas no

The CAS Registry Mumber 31602-11-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,6,0 and 2 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 31602-11:
(7*3)+(6*1)+(5*6)+(4*0)+(3*2)+(2*1)+(1*1)=66
66 % 10 = 6
So 31602-11-6 is a valid CAS Registry Number.
InChI:InChI=1/C13H9ClF3NO2/c1-2-20-12(19)8-6-18-11-7(10(8)14)4-3-5-9(11)13(15,16)17/h3-6H,2H2,1H3

31602-11-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 4-chloro-8-(trifluoromethyl)quinoline-3-carboxylate

1.2 Other means of identification

Product number -
Other names 4-chloro-8-trifluoro-quinoline-3-carboxylic acid ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:31602-11-6 SDS

31602-11-6Relevant articles and documents

Synthetic method of 8-(trifluoromethyl)quinoline-3-carboxylate

-

, (2018/09/11)

The invention provides a synthetic method of 8-(trifluoromethyl)quinoline-3-carboxylate. The synthetic method comprises the following steps: reacting 2-(trifluoromethyl)aniline serving as a starting raw material to obtain 8-(trifluoromethyl)quinoline-3-ethyl ester carboxylate; lastly, hydrolyzing the 8-(trifluoromethyl)quinoline-3-ethyl ester carboxylate in an alkaline environment to obtain 8-(trifluoromethyl)quinoline-3-carboxylate. According to the synthetic method of the 8-(trifluoromethyl)quinoline-3-carboxylate provided by the invention, a synthetic route taking 2-(trifluoromethyl)anilineas a raw material is provided. The synthetic method has the advantages of simple synthetic route, reasonable process selection, low raw material cost, adoption of simple and readily-available raw materials, convenience in operation and post-treatment, high total yield, no use of any highly-toxic reagent, easiness in amplification, realization of large-scale production and the like.

Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents

Eswaran, Sumesh,Adhikari, Airody Vasudeva,Pal, Nishith K.,Chowdhury, Imran H.

supporting information; experimental part, p. 1040 - 1044 (2010/06/14)

A series of 26 new quinoline derivatives carrying active pharmacophores has been synthesized and evaluated for their in vitro antituberculosis activity against Mycobacterium tuberculosis H37Rv (MTB), Mycobacterium smegmatis (MC2), and Mycobacterium fortuitum following the broth micro dilution assay method. Compounds 13e, 13i, 13k, 14a, 14c, 14i, and 14k exhibited significant minimum inhibition concentrations, when compared with first line drugs isoniazid (INH) and rifampicin (RIF) and could be ideally suited for further modifications to obtain more efficacious compounds in the fight against multi-drug resistant tuberculosis.

Quinolines useful in treating cardiovascular disease

-

Page/Page column 28, (2008/06/13)

This invention provides compounds of formula I that are useful in the treatment or inhibition of LXR mediated diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 31602-11-6